Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019

子宮内避妊器具の世界市場:ホルモンタイプIUD、銅タイプIUD

◆タイトル:Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019
◆商品コード:MMM-HE-1179
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年4月2日
◆ページ数:80
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,250 ⇒換算¥480,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD7,225 ⇒換算¥816,425見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、子宮内避妊器具の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、成長要因・阻害要因、種類別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。

The global intrauterine contraceptive devices market is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The growth of the intrauterine contraceptive devices market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception and less side effects of IUCD, implementation of Affordable Care Act (ACA), rising initiatives of private firms directed towards reducing the expenses related to abortion, funds/grants for IUCD products, and technological advancements. However, high cost of treatment, threat of causing pelvic inflammatory infection (PID), threat of causing ectopic pregnancy, high rate of complications during unplanned pregnancy, and need of compulsory assistance of medical professional is hampering the growth of IUCD market. Moreover, rising number of players in this segment, technological advancements are creating growth opportunities for the global intrauterine contraceptive devices market.

In this report, the market has been broadly classified on the basis of types which includes; Hormonal IUCD and Copper IUCD. The copper IUCD market segment is accounted for the largest market share of 51.9%.

Geographically, the market in Asia accounted for the largest share of 35.0% of the Global Intrauterine Contraceptive Devices market in 2014, followed by Europe. The Intrauterine Contraceptive Devices market in the U.S. is primarily driven by Affordable Care Act, technological advancements. However, stringent regulatory and reimbursement policies in U.S., threat to PID infection are hampering the growth of the Intrauterine Contraceptive Devices market in this region.

The global intrauterine contraceptive devices market is a competitive market with a number of market players. Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland) are some of the major players operating in this market. New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to strengthen their position in this market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—, market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging- and high-growth segments of the global intrauterine contraceptive devices market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on Intrauterine Contraceptive Devices offered by the top players in the Global Intrauterine Contraceptive Devices market

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the Global Intrauterine Contraceptive Devices market.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various Intrauterine Contraceptive Devices across geographies.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Global Intrauterine Contraceptive Devices market.

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the Global Intrauterine Contraceptive Devices market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 8
1.1 OBJECTIVES OF THE STUDY 9
1.2 MARKET SEGMENTATION & COVERAGE 10

2 RESEARCH METHODOLOGY 11
2.1 INTEGRATED ECOSYSTEM OF INTRAUTERINE CONTRACEPTIVE DEVICES MARKET 12
2.2 ARRIVING AT THE GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET SIZE 13
2.2.1 TOP-DOWN APPROACH 13
2.2.2 BOTTOM-UP APPROACH 14
2.2.3 MACRO INDICATOR-BASED APPROACH 15
2.3 ASSUMPTIONS 16

3 EXECUTIVE SUMMARY 17

4 MARKET OVERVIEW 19
4.1 INTRODUCTION 19
4.2 MARKET DRIVERS AND INHIBITORS 20
4.3 KEY MARKET DYNAMICS 23

5 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 26
5.1 INTRODUCTION 27
5.2 COPPER IUD 27
5.3 HORMONAL IUD 28
5.4 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, TYPE COMPARISON WITH FEMALE CONTRACEPTIVES MARKET 29
5.5 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY 31
5.6 GLOBAL HORMONAL IUD MARKET, BY GEOGRAPHY 32

6 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY PRODUCT 33
6.1 MIRENA 33
6.1.1 PRODUCT POSITIONING AND PROMOTIONS OF MIRENA 34
6.2 SKYLA 35
6.2.1 PRODUCT POSITIONING AND PROMOTIONS OF SKYLA 35
6.3 PARAGARD 36
6.3.1 PRODUCT POSITIONING AND PROMOTIONS OF PARAGARD 37
6.4 ESSURE 38
6.4.1 PRODUCT POSITIONING AND PROMOTIONS OF ESSURE 38
6.5 PIPELINE PRODUCTS 39
6.5.1 LEVOSERT 40

7 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 41
7.1 INTRODUCTION 42
7.2 ASIA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET 43
7.3 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 47
7.4 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 51
7.5 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 55

8 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPETITIVE LANDSCAPE 59
8.1 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS 59
8.2 MERGERS & ACQUISITIONS 60
8.3 REGULATORY APPROVALS 60
8.4 PARTNERSHIP 61
8.5 COLLABORATION 61

9 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COMPANY 62
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BAYER HEALTHCARE AG (SUBSIDIARY OF BAYER AG) 62
9.2 TEVA PHARMACEUTICAL INDUSTRIES LTD. 66
9.3 ACTAVIS PLC 69
9.4 MEDICINE360 71
9.5 TRIMEDIC SUPPLY NETWORK LTD. 72
9.6 MEDISAFE DISTRIBUTION INC. 73
9.7 PACE PHARMACEUTICALS, INC. 74
9.8 SMB CORPORATION 75
9.9 OCON MEDICAL LTD. 76
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company

10 APPENDIX 77
10.1 RELATED REPORTS 77
10.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 78
10.2.1 RT SNAPSHOTS 79

LIST OF TABLES

TABLE 1 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: MACRO INDICATORS, BY REGION, 2008 (ABORTION PER 1000 WOMEN AGES 15-44) 16
TABLE 2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: DRIVERS AND INHIBITORS 20
TABLE 3 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPARISON WITH GLOBAL FEMALE CONTRACEPTIVES MARKET, 2013 - 2019 (USD MN) 24
TABLE 4 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY,
2013 - 2019 (USD MN) 24
TABLE 5 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE,
2013 - 2019 (USD MN) 25
TABLE 6 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: TYPE COMPARISON WITH FEMALE CONTRACEPTIVES MARKET, 2013–2019 (USD MN) 30
TABLE 7 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY, 2013 - 2019 (USD MN) 31
TABLE 8 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY, 2013 - 2019 (USD MN) 32
TABLE 9 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY ,
2013 - 2019 (USD MN) 42
TABLE 10 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE,
2013 -2019 (USD MN) 42
TABLE 11 ASIA :INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 43
TABLE 12 ASIA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE,
2013-2019 (USD MN) 44
TABLE 13 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY,
2013-2019 (USD MN) 47
TABLE 14 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 48
TABLE 15 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET,
BY GEOGRAPHY 51
TABLE 16 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 52
TABLE 17 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 55
TABLE 18 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 56
TABLE 19 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 59
TABLE 20 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET:
MERGERS & ACQUISITIONS 60
TABLE 21 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: REGULATORY APPROVALS 60
TABLE 22 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: PARTNERSHIP 61
TABLE 23 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COLLABORATION 61
TABLE 24 BAYER HEALTHCARE AG.: KEY FINANCIALS, 2008 - 2013 (USD MN) 63
TABLE 25 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY FINANCIALS, 2008 - 2013 (USD MN) 66
TABLE 26 ACTAVIS PLC: KEY FINANCIALS, 2008 - 2013 (USD MN) 69


LIST OF FIGURES

FIGURE 1 EVOLUTION OF INTRAUTERINE CONTRACEPTIVE DEVICES (IUD/IUCD) 8
FIGURE 2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET:
SEGMENTATION & COVERAGE 10
FIGURE 3 INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: INTEGRATED ECOSYSTEM 12
FIGURE 4 TOP-DOWN APPROACH 14
FIGURE 5 BOTTOM-UP APPROACH 15
FIGURE 6 MACRO INDICATOR-BASED APPROACH 15
FIGURE 7 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET SNAPSHOT 18
FIGURE 8 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPARISON WITH GLOBAL FEMALE CONTRACEPTIVES MARKET 23
FIGURE 9 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES, BY REGION,
2014 & 2019 (USD MN) 24
FIGURE 10 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE,
2014 & 2019 (USD MN) 25
FIGURE 11 ADVANTAGES & DISADVANTAGES OF COPPER IUD 27
FIGURE 12 ADVANTAGES & DISADVANTAGES OF HORMONAL IUD 28
FIGURE 13 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE,
2012 - 2018 (USD MN) 29
FIGURE 14 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: TYPE COMPARISON WITH FEMALE CONTRACEPTIVES MARKET, 2013–2019 (USD MN) 29
FIGURE 15 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY , 2013 - 2019 (USD MN) 31
FIGURE 16 GLOBAL HORMONAL IUD MARKET, BY GEOGRAPHY, 2013 - 2019 (USD MN) 32
FIGURE 17 ADVERSE EFFECTS CAUSED BY MIRENA, U.S., 1997-2012 34
FIGURE 18 ASIA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 43
FIGURE 19 ASIA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 44
FIGURE 20 ASIA: INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 45
FIGURE 21 ASIA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: BY TYPECOMPARISION WITH FEMALE CONTRACEPTIVE DEVICES MARKET (2013-2019) 45
FIGURE 22 ASIA : COPPER INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, (2013-2019) 46
FIGURE 23 ASIA: HORMONAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, (2013-2019) 46
FIGURE 24 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 47
FIGURE 25 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 48
FIGURE 26 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPES 49
FIGURE 27 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: BY TYPE COMPARISON WITH FEMALE CONTRACEPTIVE DEVICES MARKET (2013-2019) 49
FIGURE 28 EUROPE : COPPER INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, (2013-2019) 50
FIGURE 29 EUROPE : HORMONAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET,
(2013-2019) 50
FIGURE 30 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET,
BY GEOGRAPHY 51
FIGURE 31 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPES 52
FIGURE 32 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 53
FIGURE 33 NORTH AMERICA :INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: BY TYPES COMPARISON WITH FEMALE CONTRACEPTIVE DEVICES MARKET (2013-2019) 53
FIGURE 34 NORTH AMERICA : HORMONAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, (2013-2019) 54
FIGURE 35 NORTH AMERICA : COPPER INTRAUTERINE CONTRACEPTIVE DEVICES MARKET,
(2013-2019) 54
FIGURE 36 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 55
FIGURE 37 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 56
FIGURE 38 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPES 57
FIGURE 39 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: BY TYPES COMPARISON WITH FEMALE CONTRACEPTIVE DEVICES MARKET (2013-2019) 57
FIGURE 40 ROW HORMONAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2013-2019 58
FIGURE 41 ROW COPPER INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, (2013-2019) 58
FIGURE 42 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 59
FIGURE 43 BAYER HEALTHCARE AG: REVENUE MIX (2013) (%) 62
FIGURE 44 CONTRIBUTION OF PHARMACEUTICALS SEGMENT TOWARDS COMPANY REVENUES, 2008-2013 (USD MN) 63
FIGURE 45 TEVA PHARMACEUTICAL INDUSTRIES LTD.: REVENUE MIX (2013) (%) 66
FIGURE 46 CONTRIBUTION OF SPECIALITY MEDICINE SEGMENT TOWARDS COMPANY REVENUES, 2008-2013 (USD MN) 67
FIGURE 47 ACTAVIS PLC: REVENUE MIX (2013) (%) 69

【レポートのキーワード】

子宮内避妊器具、避妊器具、妊娠、医療機器、ホルモンタイプIUD、銅タイプIUD

★調査レポート[子宮内避妊器具の世界市場:ホルモンタイプIUD、銅タイプIUD] ( Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019 / MMM-HE-1179) 販売に関する免責事項
[子宮内避妊器具の世界市場:ホルモンタイプIUD、銅タイプIUD] ( Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019 / MMM-HE-1179) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆